What do guidelines suggest regarding stenting pre or post Extracorporeal Shock Wave Lithotripsy (ESWL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stenting Around ESWL: Guideline Recommendations

Routine stenting before ESWL should not be performed, as it does not improve stone-free rates and may increase patient morbidity. 1

Pre-ESWL Stenting

The most recent 2025 European Association of Urology guidelines are unequivocal on this matter:

  • Routine prestenting before ESWL does not improve stone-free rates but may reduce steinstrasse (stone street formation). 1

  • The American Urological Association/Endourological Society guidelines similarly state that routine stenting should not be performed in patients undergoing SWL (Strong Recommendation; Evidence Strength: Grade B). 1

Nuanced Exception for Renal Stones

While routine prestenting is not recommended, the EAU guidelines note that prestenting may improve treatment outcomes specifically for renal stones (not ureteral stones). 1 This is a selective consideration, not a blanket recommendation.

Evidence Supporting No Routine Prestenting

Multiple research studies support the guideline position:

  • A 2012 prospective randomized study found that pre-treatment stenting significantly lowered stone-free rates (68.6% vs 83.7%, p=0.026) and was associated with increased post-treatment lower urinary tract symptoms, need for more ESWL sessions, and higher operation rates due to ESWL failure. 2

  • A 2010 study of impacted upper ureteral stones showed no significant difference in stone-free rates between stented (90%) and non-stented (86.7%) groups (p=0.346), while stented patients experienced significantly more dysuria, urgency, frequency, and suprapubic pain. 3

  • A 1991 randomized trial of large renal calculi found that ureteral stents did not reduce post-ESWL complications and were clearly associated with morbidity including stent calcification (in stents left longer), migration, and bladder discomfort in almost half of patients. 4

  • Even in pediatric populations, a 2025 study of 277 renal units showed no significant difference in stone-free rates (60.6% vs 68.4%, p=0.36) or complication rates (15.2% vs 14.3%, p=0.79) between stented and non-stented groups. 5

Post-ESWL Stenting

Post-ESWL stenting is not addressed separately in the guidelines, as the stenting recommendations provided apply to the context of URS (ureteroscopy), not ESWL. 1

For URS procedures, the guidelines specify:

  • Routine post-URS stenting is unnecessary after uncomplicated procedures and may increase morbidity. 1
  • Stenting is advised in cases with trauma, residual fragments, bleeding, perforation, UTI, or pregnancy. 1

Clinical Algorithm for Stenting Decisions with ESWL

For most patients undergoing ESWL:

  • Proceed without prestenting 1

Consider selective prestenting only if:

  • Large renal stones (>200 mm² stone burden) where improved outcomes may justify the morbidity trade-off 1
  • Anatomic obstruction distal to the stone (which is actually a contraindication to ESWL itself) 1

Accept that prestenting may reduce steinstrasse risk but:

  • This benefit does not outweigh the decreased stone-free rates and increased patient morbidity 1, 2
  • Steinstrasse occurs in only 4% of ESWL cases overall 1

Common Pitfalls to Avoid

  • Do not routinely stent "just to be safe" – the evidence shows this approach worsens outcomes and increases patient suffering. 1, 3, 2

  • Do not confuse URS stenting recommendations with ESWL stenting – these are different procedures with different evidence bases. 1

  • If a stent is placed, remove it promptly – prolonged stenting leads to calcification and migration complications. 4

  • Use alpha-blockers to improve stent tolerability if stenting is deemed necessary for specific clinical reasons. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.